Making HPV vaccines efficient: Cost-Effectiveness Analysis and the Economic Assemblage of Healthcare in Colombia
Cost-effectiveness analysis (CEA) is a strategy of calculation whose main objective is to compare for making decisions about the best, the most efficient solution (costs vs. benefits) to a particular problem. Cost-effectiveness analysis not only provides a framework to compare healthcare interventions which in practice seem incommensurable; it also performs a set of assumptions regarding the nature of healthcare and the behaviour of individuals. This article analyses the role of CEA as a device to produce value in the introduction of HPV vaccines in Colombia. In the different institutional pathways and decision-making scenarios cost-effectiveness has been the key issue that justified the inclusions and the exclusions that such technology entails. Cost-effectiveness has justified the definition of girls as the population target and the exclusion of boys from risks and benefits of this technology. Moreover, cost-effectiveness analysis has been a key instrument in the sexualising and de-sexualising of cervical cancer and HPV vaccines through the rationalisation of economic benefits.
Adams V, Murphy M and Clarke A (2009) Anticipation: Technoscience, Life, Affect, Temporality. Subjectivity 28: 246–265.
Biehl J (2012) Between the Court and the Clinic: Lawsuits for Medicines and the Right to Health in Brazil. Health and Human Rights: An International Journal 14(1): 1–17
Bielhl J and Petryna A (2011) Bodies of Rights and Therapeutic Markets. Social Research 78(2): 359–386.
Bosch FX, Lorincz A, Munoz N, Meijer C and Shah KV (2002) The Causal Relation between Human Papillomavirus and Cervical Cancer. Journal of Clinical Pathology 55(4): 244–265.
Çalişkan K and Callon M (2009) Economization, part 1: Shifting Attention from the Economy Towards Processes of Economization. Economy and Society 38(3): 369–398.
Çalişkan K and Callon M (2010) Economization, part 2: A Research Programme for the Study of Markets. Economy and Society 39(1): 1–32.
Callon M and Law J (2005) On Qualculation, Agency, and Otherness. Environment and Planning D: Society and Space 23(5): 717–733.
Cellini S and Kee J (2010) Cost-Effectiveness and Cost-Benefit Analysis. In: Wholey J, Hatry H and Newcomer K (eds) Handbook of Practical Program Evaluation, 3rd ed. San Francisco, CA: Jossey-Bass, pp. 493-530.
Clark AM (2005) New Civic Epistemologies of Quantification: Making Sense of Local and Global Indicators of Sustainability. Science, Technology & Human Values 30(3): 403–432.
Collier S (2006) Global Assemblages. Theory Culture Society 23(2–3): 39–9401.
Council of State (2012) Class Action. Radication No 25000 2315 000 2010 02728 01. Actor: María Teresa Tovar Rojas. Author: Doctor Marco Antonio Velilla Moreno. 16 February 2012. Bogotá: Council of State.
Desrosières A (1998) The Politics of Large Numbers: A History of Statistical Reasoning. Cambridge, MA: Harvard University Press.
Ecks S (2008) Global Pharmaceutical Markets and Corporate Citizenship: The Case of Novartis' Anti-cancer Drug Glivec. BioSocieties 3(2): 165–181.
Espeland W and Stevens M (2009) A Sociology of Quantification. European Journal of Sociology [Archives Européennes de Sociologie] 49(3): 401–436.
Fourcade M (2011) Cents and Sensibility, Economic Valuation and the Nature of 'Nature' in France and America. American Journal of Sociology 116(6): 1721–1777.
Hacking I (1990) The Taming of Chance. Cambridge: Cambridge University Press.
Hillemanns P, Breugelmans JG, Gieseking F, et al. (2008) Estimation of the Incidence of Genital Warts and the Cost of Illness in Germany: A Cross-Sectional Study. BMC Infectious Diseases 2: 8–76.
Jasanoff S (2004) Designs on Nature: Science and Democracy in Europe and the United States. Princeton, NJ: Princeton University Press.
Kenny K (2015) The Biopolitics of Global Health: Life and Death in Neoliberal Time. Journal of Sociology 51(1): 9–27.
Kjellberg H, Mallard A, Arjaliés DL, et al. (2013) Valuation Studies? Our Collective Two Cents. Valuation Studies 1(1): 11–30.
Lampland M (2010) False Numbers as Formalizing Practices. Social Studies of Science 40(3): 377–404.
Latour B (2004) Why Has Critique Run Out of Steam? From Matter of Fact to Matters of Concern. Critical Inquiry 30(Winter): 225–248.
Latour B and Woolgar S (1986) Laboratory Life: The Social Construction of Scientific Facts. Princeton, NJ: Princeton University Press.
McGoey L, Reiss J and Wahlberg A (2011) The Global Health Complex. Biosocieties 6(1): 1–9.
MacKenzie D (2006) An Engine, Not a Camera. How Financial Models Shape Markets. Cambridge, MA: MIT Press.
Maldonado O (2017) Evidence, sex and state paternalism. Intersecting global connections in the introduction of HPV vaccines in Colombia. In: Johnson E (ed) Gendering Drugs. Feminist Studies of Pharmaceuticals. London: Palgrave Macmillan.
Mamo L and Epstein S (2014) The Pharmaceuticalization of Sexual Risk: Vaccine Development and the New Politics of Cancer Prevention. Social Science & Medicine 101: 155–165.
Ministry of Health (2012a) Meeting Minute SGC-F03. Definition of Introduction of Vaccine against HPV and Hepatitis A into Extended Programme of Immunisations. National Committee of Immunisation Practices, 3rd May. Bogotá: Ministry of Health, Republic of Colombia.
Ministry of Health (2012b) Memorandum 201221102384491. Technical Concept from Ministry of Health to Colombian Congress about Bill 260 of 2012. Bogotá: Ministry of Health, Republic of Colombia (internal communication).
Moreira T (2012a) Health Care Standards and the Politics of Singularities: Shifting In and Out of Context. Science, Technology and Human Values 37: 307–331.
Moreira T (2012b) The Transformation of Contemporary Health Care. The Market, the Laboratory, and the Forum. New York and Oxford: Routledge.
Ong A and Collier S (2005) Global Assemblages, Anthropological Problems. In: Collier SJ and Ong A (eds) Global Assemblages: Technology, Politics, and Ethics as Anthropological Problems. Malden, MA: Blackwell, pp. 3-21.
Pinch T, Ashmore M and Mulkay M (2000) Cost Benefit Analysis in Practice: Option Appraisal in the UK National Health Service and the Politics of Rational Decision-Making. In: Rottenburg R, Kalthoff H and Wagener H-J (eds) Facts and Figures: Economic Representations and Practices. Ökonomie und Gesellschaft, Jahrbuch 16. Marburg: Metropolis-Verlag, pp. 87–116.
Porter T (1995) Trust in Numbers: The Pursuit of Objectivity in Science and Public Life. Princeton, NJ: Princeton University Press.
Reid BL, French PW, Singer A and Hagan BE (1978) Coppleson M. Sperm Basic Proteins in Cervical Carcinogenesis: Correlation with Socioeconomic Class. Lancet 8(2): 60–62.
Reubi D (2013) Health Economists, Tobacco Control and International Development: On the Economisation of Global Health beyond Neoliberal Structural Adjustment Policies. Biosocieties 8(2): 205–228.
Reynolds L and Tansey E (2009) History of Cervical Cancer and the Role of the Human Papillomavirus, 1960-2000. Wellcome Witnesses to Twentieth Century Medicine, vol. 38. London: Wellcome Trust.
UNAL (Universidad Nacional de Colombia) (2009) Estudio de costo-effectividad para la introducción de la vacuna contra Papiloma humano en Colombia. Bogotá: UNAL.
UNAL (Universidad Nacional de Colombia) (2011) Estudio de costo-effectividad para la introducción de la vacuna contra Papiloma humano en Colombia. Bogotá: UNAL.
Verran H (2012) The Changing Lives of Measures and Values: From Centre Stage in the Fading 'Disciplinary' Society to Pervasive Background Instrument in the Emergent 'Control' Society. The Sociological Review 59(s2): 60–72.
VSG (Victoria State Government) (2001) Victorian Burden of Disease Study. Available at: http://docs.health.vic.gov.au/docs/doc/6AEAFAB1BAE696B9CA257886000158A0/$FILE/bod_2001.pdf (accessed 5 May 2014).
Wahlberg A and Rose N (2015) The Governmentalization of Living: Calculating Global Health. Economy and Society 44(1): 60–90.
WHO (World Health Organization) (2012). Global Burden of Disease. Guidelines and Definitions. Available at: http://www.who.int/topics/global_burden_of_disease/en/ (accessed 2 December 2012).
This Science & Technology Studies website ("Site") is owned and operated by The Finnish Society for Science and Technology Studies (“Society”), PO Box 117, c/o Otto Auranen, Sepänkatu 4-8 A 16, 33230 Tampere,Finland. The Finnish Society for Science and Technology Studies and its publication Science & Technology Studies are non-profit organizations.
The Society reserves the right to change, modify, add or remove portions of these Terms and Conditions at its discretion at any time and without prior notice. Please check this page periodically for any modifications. Your continued use of this Site following the posting of any changes will mean that you have accepted the changes.Copyrights and Limitations on Use
All content in this Site, including site layout, design, images, text and other information (collectively, the "Content") is the property of The Finnish Society for Science and Technology Studies/Science & Technology Studies and is protected by copyright and other intellectual property laws, unless otherwise noted.
You may not copy, display, distribute, modify, publish, reproduce, store, transmit, create derivative works from, or sell or license all or any part of the Content, products or services obtained from this Site in any medium to anyone, except as otherwise expressly permitted under applicable law or as described in these Terms and Conditions or relevant license or subscriber agreement.
You may print or download Content from the Site for academic, your own personal, non-commercial use, provided that you keep intact all copyright and other proprietary notices. You may not engage in systematic retrieval of Content from the Site to create or compile, directly or indirectly, a collection, compilation, database or directory without prior written permission from Science & Technology Studies.
The Site may contain robot exclusion headers, and by using the Site you agree that you will not use any robots, spiders, crawlers or other automated downloading programs or devices to access, search, index, monitor or copy any Content. The harvesting of postal or email addresses from the Site for purposes of sending unsolicited or unauthorized commercial material, is prohibited. Any questions about whether a particular use is authorized and any requests for permission to publish, reproduce, distribute, display or make derivative works from any Content should be directed to the Science & Technology Studies Assistant Editor.
You may not use the services on the Site to publish or distribute any information (including software or other content) that is illegal; violates or infringes upon the rights of any other person; is abusive, hateful, profane, pornographic, threatening or vulgar; contains errors, viruses or other harmful components; or is otherwise actionable by law. Science & Technology Studies may at any time exercise editorial control over the content of any information or material that is submitted or distributed through its facilities and/or services.
You may not, without the approval of Science & Technology Studies, use the Site to publish or distribute any advertising, promotional material, or solicitation to other users of the Site to use any goods or services. For example (but without limitation), you may not use the Site to conduct any business, to solicit the performance of any activity that is prohibited by law, or to solicit other users to become subscribers of other information services. Similarly, you may not use the Site to download and redistribute public information or shareware for personal gain or use the facilities and/or services to distribute multiple copies of public domain information or shareware.Trademarks
All trademarks appearing on this Site are the property of their respective owners.Links to Other Sites
The Site may contain hyperlinks to other sites or resources that are provided solely for your convenience. Science & Technology Studies is not responsible for the availability of external sites or resources linked to the Site, and does not endorse and is not responsible or liable for any content, advertising, products or other materials on or available from such sites or resources. Transactions that occur between you and any third party are strictly between you and the third party and are not the responsibility of Science & Technology Studies. Due to the fact that Science & Technology Studies is not responsible for the availability or accuracy of these outside resources or their contents, you should review the terms and conditions and privacy policies of these linked sites, as their policies may differ from ours.
Last revised: 10 October 2012